FDA warns Cipla over poor contamination controls and minimizing problems tied to defective inhalers
Regulatory NewsJoanne S. Eglovitch
Combination products/companion diagnosticsComplianceMedical DevicesNorth AmericaPharmaceuticalsQuality Assurance and Control